Literature DB >> 7714182

Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay.

S Hashida1, K Hashinaka, I Nishikata, S Oka, K Shimada, A Saitoh, A Takamizawa, H Shinagawa, E Ishikawa.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) p24 antigen was measured by an ultrasensitive enzyme immunoassay (two-site immune complex transfer enzyme immunoassay). The antigen was reacted simultaneously with 2,4-dinitrophenyl-biotinyl-bovine serum albumin-anti-recombinant p24 (rp24) Fab' conjugate and anti-rp24 Fab'-beta-D-galactosidase conjugate. The complex that was formed, comprising the three components, was transferred from polystyrene beads coated with affinity-purified (anti-2,4-dinitrophenyl group) immunoglobulin G (IgG) to polystyrene beads coated with streptavidin. The detection limit of rp24 was 2.4 fg (0.1 amol) per assay or 0.24 pg/ml with as little as 10 microliters of serum. When sera were treated at low pH, p24 was detected in 34 (68%) of 50 serum samples from asymptomatic carriers, in 25 (86%) of 29 serum samples from patients with advanced HIV-1 infection, and in none of 117 serum samples from HIV-1-seronegative individuals. Levels of p24 in serum were inversely correlated to those of anti-HIV-1 p24 IgG, and the recovery of rp24 added to serum decreased to zero with increasing levels of anti-HIV-1 p24 IgG in serum. This sensitive method may be used as a powerful tool for investigating the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714182      PMCID: PMC227936          DOI: 10.1128/jcm.33.2.298-303.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Improved detection of HIV p24 antigen in serum after acid pretreatment.

Authors:  M A Rodríguez-Iglesias; J R Alvarez; A Vergara; M S Garcia-Valdivia; I Jesús; J Mira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.

Authors:  P Nishanian; K R Huskins; S Stehn; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction.

Authors:  M Holodniy; D A Katzenstein; S Sengupta; A M Wang; C Casipit; D H Schwartz; M Konrad; E Groves; T C Merigan
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

4.  Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.

Authors:  R E Chaisson; M D Leuther; J P Allain; S Nusinoff-Lehrman; G S Boone; D Feigal; P Volberding
Journal:  Arch Intern Med       Date:  1988-10

5.  Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients.

Authors:  D A Paul; L A Falk; H A Kessler; R M Chase; B Blaauw; D S Chudwin; A L Landay
Journal:  J Med Virol       Date:  1987-08       Impact factor: 2.327

6.  Detection of one attomole of [Arg8]-vasopressin by novel noncompetitive enzyme immunoassay (hetero-two-site complex transfer enzyme immunoassay).

Authors:  S Hashida; K Tanaka; N Yamamoto; T Uno; K Yamaguchi; E Ishikawa
Journal:  J Biochem       Date:  1991-10       Impact factor: 3.387

7.  Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial.

Authors:  G L Drusano; G J Yuen; J S Lambert; M Seidlin; R Dolin; F T Valentine
Journal:  Ann Intern Med       Date:  1992-04-01       Impact factor: 25.391

8.  Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.

Authors:  K B MacDonell; J S Chmiel; L Poggensee; S Wu; J P Phair
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

9.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Authors:  A R Moss; P Bacchetti; D Osmond; W Krampf; R E Chaisson; D Stites; J Wilber; J P Allain; J Carlson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

10.  Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

Authors:  G G Jackson; D A Paul; L A Falk; M Rubenis; J C Despotes; D Mack; M Knigge; E E Emeson
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

View more
  17 in total

1.  Use of indirectly immobilized recombinant p17 antigen for detection of antibodies to HIV-1 by enzyme immunoassay.

Authors:  S Ishikawa; K Hashinaka; S Hashida; S Oka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

Authors:  Kazuhiko Takeda; Mari Maruki; Takahiro Yamagaito; Machiko Muramatsu; Yasuhiro Sakai; Hiroaki Tobimatsu; Hironori Kobayashi; Yoshiteru Mizuno; Yukio Hamaguchi
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Rapid formation of the immune complexes on solid phase in the immune complex transfer enzyme immunoassays for HIV-1 p24 antigen and antibody IgGs to HIV-1.

Authors:  S Ishikawa; S Hashida; K Hashinaka; A Adachi; S Oka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Rapid and ultrasensitive enzyme immunoassay (thin aqueous layer immune complex transfer enzyme immunoassay) for HIV-1 p24 antigen.

Authors:  S Ishikawa; S Hashida; K Hashinaka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Immune complex transfer enzyme immunoassay for antibody IgM to HIV-1 p17 antigen.

Authors:  S Hashida; S Ishikawa; I Nishikata; K Hashinaka; S Oka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

6.  Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.

Authors:  S Ishikawa; K Hashinaka; S Hashida; S Oka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

7.  Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.

Authors:  S Hashida; S Ishikawa; K Hashinaka; I Nishikata; S Oka; K Shimada; A Saito; A Takamizawa; H Shinagawa; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

8.  Ultrasensitive and rapid enzyme immunoassay (thin aqueous layer immune complex transfer enzyme immunoassay) for antibody IgG to HIV-1 p17 antigen.

Authors:  S Ishikawa; S Hashida; K Hashinaka; A Adachi; S Oka; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

9.  More sensitive immune complex transfer enzyme immunoassay for antibody IgG to p17 of HIV-1 with shorter incubation time for immunoreactions and larger volumes of serum samples.

Authors:  S Ishikawa; S Hashida; K Hashinaka; M Kojima; A Saito; A Takamizawa; H Shinagawa; S Oka; K Shimada; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

10.  Potential of the immune complex transfer enzyme immunoassay for antigens and antibodies to improve the sensitivity and its limitations.

Authors:  E Ishikawa; S Ishikawa; S Hashida; K Hashinaka
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.